Written by
in
The investigational oral amyloid-targeting agent valiltramiprosate (ALZ-801) significantly slowed brain atrophy and cognitive decline in people carrying 2 copies of the APOE ε4 allele, the strongest genetic risk factor for Alzheimer disease…
